id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-350094-nkzbtcfw	Barrett, Lisa F.	Self-Limited Gastrointestinal Bleeding in COVID-19	2020-07-15		.txt	text/plain	649	52	53	Clinicians should be aware of a possible increased risk of GI bleeding and its complications when managing critically ill COVID-19 patients. SARS-CoV-2, a single-stranded RNA virus of the beta coronavirus genus, enters the body via the angiotensin converting enzyme 2 (ACE2) receptor [2] [3] . ACE2 is expressed in gastrointestinal (GI) epithelial cells suggesting that SARS-CoV-2 can infect and replicate in the GI tract [4] . We present a case series of six patients, most without a known source of GI bleeding, who tested positive for SARS-CoV-2 and concurrently suffered from hematochezia or melena. We recorded cases of SARS-CoV-2 infection and concurrent GI bleeding from March 1, 2020 to April 24, 2020. Coagulopathy is associated with SARS-CoV-2 infection. Given the possible increased risk of bleeding in COVID-19, therapeutic anticoagulation in infected patients should be used cautiously. This case series shows a possible increased risk of bleeding among patients with COVID-19.	./cache/cord-350094-nkzbtcfw.txt	./txt/cord-350094-nkzbtcfw.txt